• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Generic blood pressure drugs approved

      Posted AtBusinessweek.com

      Mylan Inc. said Friday it received approval to start selling generic versions of Merck and Co.'s blood pressure drugs Cozaar and Hyzaar.

      The drugmaker from Canonsburg, Pa., has now received marketing approval for several doses of the drugs, but it was not able to sell them until this month. Its competitor Teva Pharmaceutical Industries Ltd. was the first company to file for approval of generic versions of the drug, so other versions were barred from the market for six months. Teva received FDA clearance in April.

      The newly approved versions of the drug are ready for shipping immediately, Mylan said.

      Combined, Cozaar and Hyzaar were Merck's second best selling product. Mylan said U.S. sales of Cozaar totaled $940 million over the 12 months ended June 30, while Hyzaar sales totaled $570 million. Merck's sales fell by almost half after Teva started selling its generics.

      Mylan shares rose 2 cents to $18.96 in morning trading Friday.

      Oct 22, 2010


       

      Share this Article!

    Back to top^